Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001-2005.
Wiessing
L
L
European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal. Lucas.Wiessing@emcdda.europa.eu
Nardone
A
A
D001454:Baltic States / Q000453:epidemiology; D015897:Comorbidity; D004866:Equipment Contamination; D005060:Europe / Q000453:epidemiology; D005062:European Union; D015658:HIV Infections / Q000453:epidemiology* / Q000635:transmission; D015528:HIV Seroprevalence; D006509:Hepatitis B / Q000453:epidemiology* / Q000635:transmission; D017325:Hepatitis B Vaccines; D006526:Hepatitis C / Q000453:epidemiology* / Q000635:transmission; D006801:Humans; D015994:Incidence; D007275:Injections, Intravenous / Q000009:adverse effects / Q000295:instrumentation; D018671:Needle-Exchange Programs; D011159:Population Surveillance / Q000379:methods; D015397:Program Evaluation; D015819:Substance Abuse, Intravenous / Q000453:epidemiology*; D014611:Vaccination / Q000706:statistics & numerical data
D017325:Hepatitis B Vaccines